← Leaderboards
Madeleine Janette Sitton
Duke University
$163,029
Attributed
$163,029
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $94.1K · FY2022–25$100K$75K$50K$25K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$163,029 · 2
By mechanism
K00$94,091 · 1
F99$68,938 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Dwight D Koeberl$10,403,079
- Kevin Shores$84,828
- Sidney M Gospe$2,029,982
- Patrick Juras$82,428
Others in their field
Other Rising Stars on “Pathway Interactions”
- Sabrina Paganoni · Massachusetts General Hospital$15,344,018
- Suma Babu · Massachusetts General Hospital$15,344,018
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Stanley Wang · Aligos Therapeutics, Inc.$8,469,477
- Matthew Morrow Engelhard · Duke University$7,519,665
- Eileen Mary O'Reilly · Sloan-Kettering Inst Can Research$7,024,010
Research focus
Pathway InteractionsTrainingGeneticNf1 GeneResponseSignal TransductionGene TherapyDesignMonitorNeurofibromatosis 1ProteinsExperimental StudySchwann CellsCell LineAffectGenesCellsCancer BiologyGuide RnaMalignant NeoplasmsMutateMutationPhysiologicalTumor
Grant awards (3)
Dissecting Mechanism of Neurofibromin Regulation in the Context of Sporadic Cancers and Neurofibromatosis Type 1$94,091
K00 · FY2025 · CA · contact PI
Gene Therapy for the Treatment of Neurofibromatosis Type I (NF1)$34,190
F99 · FY2023 · CA · contact PI
Gene Therapy for the Treatment of Neurofibromatosis Type I (NF1)$34,748
F99 · FY2022 · CA · contact PI